Atossa Therapeutics's total assets for Q2 2026 were $32.28M, a decrease of -14.92% from the previous quarter. MX:ATOS total liabilities were $5.45M for the fiscal quarter, a -26.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.